Netflix and other media stocks tumble on Trump's pledge to hit foreign films with 100% tariff
Trump said he would instruct the Commerce Department to implement a 100% foreign film tariff to fix Hollywood's "very fast death."
S&P 500 Gains & Losses Today: Index Snaps Winning Streak Ahead of Fed Meeting
The S&P 500 slipped 0.6% on Monday, May 5, 2025, breaking a nine-day winning streak ahead of this week's interest-rate decision by the Federal Open Market Committee.
Inter Parfums (NASDAQ:IPAR) Beats Q1 Sales Targets
Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) announced better-than-expected revenue in Q1 CY2025, with sales up 4.6% year on year to $338.8 million. The company expects the full year’s revenue to be around $1.51 billion, close to analysts’ estimates. Its GAAP profit of $1.32 per share was 17.3% above analysts’ consensus estimates.
BellRing Brands (NYSE:BRBR) Surprises With Q1 Sales But Stock Drops
Nutrition products company Bellring Brands (NYSE:BRBR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 18.9% year on year to $588 million. On the other hand, the company’s full-year revenue guidance of $2.3 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.53 per share was in line with analysts’ consensus estimates.
Playa Hotels & Resorts’s (NASDAQ:PLYA) Q1 Earnings Results: Revenue In Line With Expectations
Hospitality company Playa Hotels & Resorts (NASDAQ:PLYA) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 11.1% year on year to $267.3 million. Its non-GAAP profit of $0.37 per share was 12% above analysts’ consensus estimates.
Matson (NYSE:MATX) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
Maritime transportation company Matson (NYSE:MATX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.3% year on year to $782 million. Its GAAP profit of $2.18 per share was 3.8% below analysts’ consensus estimates.
Mattel (NASDAQ:MAT) Delivers Strong Q1 Numbers
Toy manufacturing and entertainment company (NASDAQ:MAT) announced better-than-expected revenue in Q1 CY2025, with sales up 2.1% year on year to $826.6 million. Its non-GAAP loss of $0.03 per share was 70.4% above analysts’ consensus estimates.
Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops
Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s full-year revenue guidance of $925 million at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.17 per share was 20.8% above analysts’ consensus estimates.
Addus HomeCare (NASDAQ:ADUS) Misses Q1 Revenue Estimates
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share was 6.5% above analysts’ consensus estimates.
JELD-WEN (NYSE:JELD) Beats Q1 Sales Targets But Stock Drops
Building products manufacturer JELD-WEN (NYSE:JELD) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 19.1% year on year to $776 million. Its non-GAAP loss of $0.17 per share was 10.2% above analysts’ consensus estimates.